You have 9 free searches left this month | for more free features.

13-119

Showing 1 - 25 of 7,972

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hearing Protection Equipment in Occurence of Acute Acoustic

Completed
  • Acoustic Trauma
  • Questionnaire
  • Angers, France
  • +6 more
Sep 12, 2022

Weight Loss Trial in United States (VK2735, Placebo)

Recruiting
  • Weight Loss
  • VK2735
  • Placebo
  • Birmingham, Alabama
  • +19 more
Sep 28, 2023

Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

Active, not recruiting
  • Cystic Fibrosis (CF)
  • Mobile, Alabama
  • +46 more
Oct 20, 2022

Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))

Not yet recruiting
  • Type 2 Diabetes
  • NPM-119 (exenatide implant)
  • Bydureon BCise (exenatide extended release)
  • (no location specified)
Jan 29, 2023

Osteoarthritis, Gonarthrosis Trial in Rio De Janeiro (Photomodulation Therapy, Control)

Not yet recruiting
  • Osteoarthritis
  • Gonarthrosis
  • Photomodulation Therapy
  • Control
  • Rio De Janeiro, Brazil
    Hospital Glória D'Or
Jul 27, 2023

Lung Cancer Trial in Worldwide (Itacitinib, Osimertinib)

Active, not recruiting
  • Lung Cancer
  • La Jolla, California
  • +30 more
Mar 8, 2022

Type2Diabetes Trial in Chengdu (PB119)

Not yet recruiting
  • Type2Diabetes
  • Chengdu, Sichuan, China
    Jia Miao
Apr 12, 2022

Crow's Feet Trial in Seoul (DKB-119)

Active, not recruiting
  • Crow's Feet
  • DKB-119
  • Seoul, Korea, Republic of
    Chungang-University Hospital
Aug 28, 2023

Healthy Volunteers Trial (ARGX-119, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • ARGX-119
  • Placebo
  • (no location specified)
Jan 2, 2023

Advanced Solid Tumor Trial in Philadelphia (ATRN-119)

Not yet recruiting
  • Advanced Solid Tumor
  • Philadelphia, Pennsylvania
    Jordan Center for Gynecologic Oncology at Penn Perelman Center f
Jun 29, 2022

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • Birmingham, Alabama
  • +120 more
Dec 22, 2022

Papulopustular Rosacea Trial in United States (FMX103 1.5%)

Completed
  • Papulopustular Rosacea
  • FMX103 1.5%
  • Glendale, Arizona
  • +78 more
Jan 13, 2022

(SNPs) in Metalloproteinases Genes With Risk of Primary Knee

Recruiting
  • Metalloproteinase SNPs -1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13 and Risk for Developing Knee Osteoarthritis in Greek Population
  • No intervention, Patients selection based on clinical symptoms and radiological imaging
  • Thessaloníki, Athens, Greece
    3rd Orthopedic Department , Pagageorgiou Hospital
Aug 17, 2022

Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • efgartigimod PH20 SC
  • +2 more
  • Birmingham, Alabama
  • +130 more
Dec 22, 2022

Metastatic Triple Negative Breast Cancer Trial (pembrolizumab, capecitabine, eribulin)

Completed
  • Metastatic Triple Negative Breast Cancer
  • pembrolizumab
  • +4 more
  • (no location specified)
Nov 9, 2021

Obesity Trial in Phoenix (Hypertonic saline infusion, Water deprivation)

Completed
  • Obesity
  • Hypertonic saline infusion
  • Water deprivation
  • Phoenix, Arizona
    NIDDK, Phoenix
Jan 26, 2023

Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

Completed
  • Advanced Epithelial Ovarian
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in United States (Live, attenuated, recombinant dengue serotypes 1, 2, 3,

Completed
  • Dengue
  • +3 more
  • Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
  • Yellow Fever
  • Alabaster, Alabama
  • +6 more
Mar 15, 2022

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (eculizumab)

Completed
  • Neuromyelitis Optica
  • Neuromyelitis Optica Spectrum Disorder
  • eculizumab
  • Scottsdale, Arizona
  • +68 more
Jul 25, 2022

Graft-versus-Host Disease, Immune System Disorders Trial in United States (Mycophenolate Mofetil, Placebo)

Completed
  • Graft-versus-Host Disease
  • Immune System Disorders
  • Mycophenolate Mofetil
  • Placebo
  • Duarte, California
  • +35 more
Dec 7, 2022

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • La Jolla, California
  • +159 more
Jan 23, 2023

Depressive Disorder, Depression, Depression, Postpartum Trial in United States (Ganaxolone, Placebo)

Completed
  • Depressive Disorder
  • +9 more
  • Glendale, California
  • +32 more
Jan 4, 2023

Relapsed or Refractory Follicular Lymphoma With Enhancer of

Recruiting
  • Lymphoma, Follicular
  • Anjo-shi, Aichi, Japan
  • +174 more
Dec 12, 2022

Heart Failure, Reduced Ejection Fraction Trial in Sassari (Virtual reality)

Not yet recruiting
  • Heart Failure
  • Reduced Ejection Fraction
  • Virtual reality
  • Sassari, Italy
    Valentina Micheluzzi
Oct 30, 2023